ZCG-Backed Unimed Appoints Jesper Lok to Board of Directors

Brings 30+ Years of International Board and Executive Leadership Experience to Support Company’s Growth Initiatives

NEW YORK--(BUSINESS WIRE)--Universal Marine Medical Supply International (“Unimed” or the “Company”), the leading global provider of pharmaceutical and medical solutions to the maritime industry and a ZCG portfolio company, today announced the appointment of Jesper Lok to its Board of Directors.

Unimed’s Board of Directors, with the addition of Mr. Lok, aims to drive the Company’s success by supporting Chief Executive Officer Alan Kessman and the management team in further strengthening Unimed’s global leadership and achieving its growth initiatives.

Mr. Lok brings more than 30 years of international Board and executive leadership experience to Unimed, including 25 years in various senior positions across Asia, Europe and Africa at Maersk, a global integrated logistics company. He has hands-on experience leading growth and transformation strategies at global, multi-segment companies in a cross section of industries, including transportation and logistics, energy, infrastructure, retail and service. While at Maersk, he served as CEO of Svitzer, a leading global towage operator, from 2004 to 2012, and CEO of DSB, the largest Danish train operating company, from 2012 to 2014. Since 2014, his Board service has included Cadeler, Danmarks Skibskredit (Danish Ship Finance), ESVAGT A/S, Global Maritime Forum, Inchcape Shipping Services, Lauritzen Bulkers, Silverstream Technologies and World Marine Offshore, among other listed and sponsor-backed companies as well as foundations.

“We are delighted to welcome Jesper to the Unimed Board of Directors. His extensive experience in the maritime, shipping, and logistics industries will be instrumental in executing the Company’s global growth strategy,” said James Zenni, Founder, President and Chief Executive Officer of ZCG. “We anticipate leveraging Jesper’s business acumen and robust international relationships to gain valuable insights and guidance.”

"It is a privilege to join the Unimed Board and contribute to the Company’s management team and ZCG in building on recent momentum to achieve continued success in serving clients and marine traffic globally,” Jesper Lok said.

Unimed specializes in providing a wide range of mission-critical medical and clinical supplies, including oxygen, surgery equipment, vaccines and pharmaceutical products. The Company also provides services such as oversight of procurement and replenishment, compliance audit and advisory, and clinical facilities management. Unimed currently serves approximately 10,000 ships per year from 10 worldwide offices and access to over 2,000 ports. Earlier this month, the Company completed its merger with Singapore-based medical supplier Marine Pharma and established a distribution center in the region, in addition to existing distribution centers in New York, Miami, Southampton, UK, Athens, Greece and Perth, Australia.

About Unimed
Unimed is the industry leader in medical supply, equipment and oxygen distribution to global maritime industries, specializing in the delivery of integrated healthcare and safety supply chain logistical solutions to clients worldwide.

For more information, please visit https://universalmarinemedical.com/.

About ZCG
ZCG is a leading, privately held merchant bank comprised of private markets asset management, business consulting services, technology development and solutions.

For almost 30 years, ZCG Principals have invested tens of billions of capital and have industry leading track records in private equity and credit.

ZCG has approximately $7B of AUM in asset management and its investors are some of the largest and most sophisticated global institutional investors including pension funds, endowments, foundations, sovereign wealth funds, central banks, and insurance companies.

ZCG has a global team comprised of approximately 400 professionals.

For more information, please visit www.zcg.com.